These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15450345)

  • 1. Psoriasis: future research needs and goals for the twenty-first century.
    Griffiths CE
    Dermatol Clin; 2004 Oct; 22(4):493-9, x. PubMed ID: 15450345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical considerations in future psoriasis therapies.
    Riddle C; Young M; Menter A
    Dermatol Clin; 2004 Oct; 22(4):487-92, x. PubMed ID: 15450344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinician's paradigm in the treatment of psoriasis.
    Lebwohl M
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S59-69. PubMed ID: 15968265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment goals in psoriasis.
    Reich K; Mrowietz U
    J Dtsch Dermatol Ges; 2007 Jul; 5(7):566-74. PubMed ID: 17610606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Psoriasis and mud bath therapy: clinical-experimental study].
    Costantino M; Lampa E
    Clin Ter; 2005; 156(4):145-9. PubMed ID: 16342515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palmoplantar psoriasis: a phenotypical and clinical review with introduction of a new quality-of-life assessment tool.
    Farley E; Masrour S; McKey J; Menter A
    J Am Acad Dermatol; 2009 Jun; 60(6):1024-31. PubMed ID: 19467374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The International Dermatology Outcome Measures Group: formation of patient-centered outcome measures in dermatology.
    Gottlieb AB; Levin AA; Armstrong AW; Abernethy A; Duffin KC; Bhushan R; Garg A; Merola JF; Maccarone M; Christensen R
    J Am Acad Dermatol; 2015 Feb; 72(2):345-8. PubMed ID: 25486914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy outcomes in psoriasis: why do we know so little?
    Horn EJ; Chambers CD; Menter A; Kimball AB;
    J Am Acad Dermatol; 2009 Aug; 61(2):e5-8. PubMed ID: 19615534
    [No Abstract]   [Full Text] [Related]  

  • 10. Initiative for quality in psoriasis and psoriatic arthritis.
    Boehncke WH; Adebajo A; Cauli A; Nash P; Salvarani C; Kavanaugh AF
    J Rheumatol; 2008 Jul; 35(7):1431-3. PubMed ID: 18609739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severity levels in psoriasis: a separate 'very severe' category not required.
    Kulkarni AS; Horn E; Balkrishnan R; Feldman S
    J Dermatolog Treat; 2009; 20(1):48-51. PubMed ID: 18651301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Consensus document on the evaluation and treatment of moderate-to-severe psoriasis. Spanish psoriasis group of the Spanish Academy of Dermatology and Venereology].
    Puig L; Bordas X; Carrascosa JM; Daudén E; Ferrándiz C; Hernanz JM; López-Estebaranz JL; Moreno JC; Sánchez-Carazo JL; Vanaclocha F; Vázquez-Veiga H;
    Actas Dermosifiliogr; 2009 May; 100(4):277-86. PubMed ID: 19463230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No long-term changes in psoriasis severity and quality of life following climate therapy.
    Wahl AK; Mørk C; Cooper BA; Padilla G
    J Am Acad Dermatol; 2005 Apr; 52(4):699-701. PubMed ID: 15793527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasis assessment tools in clinical trials.
    Feldman SR; Krueger GG
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii65-8; discussion ii69-73. PubMed ID: 15708941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
    de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
    Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involving the patient: impact of inflammatory skin disease and patient-focused care.
    Feldman S; Behnam SM; Behnam SE; Koo JY
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S78-85. PubMed ID: 15968267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of inpatient treatment on quality of life and clinical disease severity in atopic dermatitis and psoriasis vulgaris - a prospective study.
    Schmitt J; Heese E; Wozel G; Meurer M
    Dermatology; 2007; 214(1):68-76. PubMed ID: 17191051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decision points for the initiation of systemic treatment for psoriasis.
    Feldman SR; Koo JY; Menter A; Bagel J
    J Am Acad Dermatol; 2005 Jul; 53(1):101-7. PubMed ID: 15965429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of vitiligo on self-reported health-related quality of life.
    Ongenae K; Van Geel N; De Schepper S; Naeyaert JM
    Br J Dermatol; 2005 Jun; 152(6):1165-72. PubMed ID: 15948977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.